Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 901

    Article Cited by others


The reason for regimen change among HIV/AIDS patients initiated on first line highly active antiretroviral therapy in Southern Ethiopia

Woldemedhin Beharu, Wabe Nasir Tajure

Year : 2012| Volume: 4| Issue : 1 | Page no: 19-23

   This article has been cited by
1 Magnitude and predictors of first-line antiretroviral therapy regimen change among HIV infected adults: A retrospective cross sectional study
Niguse Meles Alema, Solomon Weldegebreal Asgedom, Mahlet Maru, Beletu Berihun, Teklu Gebrehiwet, Tesfay Mehari Atey, Desalegn Getnet Demsie, Abere Tilahun Bantie, Adane yehualaw, Chernet Taferre, Sofia Assen Seid, Timsel Girma, Mengesha Dessie Allene, Sintayehu Mulugeta Tamru
Annals of Medicine and Surgery. 2022; : 104303
[Pubmed]  [Google Scholar] [DOI]
2 Incidence and predictors of mortality among adolescents on antiretroviral therapy in Amhara Region, Ethiopia: a retrospective cohort analysis
Cheru Tesema Leshargie, Daniel Demant, Sahai Burrowes, Jane Frawley
BMJ Open. 2022; 12(11): e063879
[Pubmed]  [Google Scholar] [DOI]
3 First line antiretroviral treatment failure and its association with drug substitution and sex among children in Ethiopia: systematic review and meta-analysis
Seteamlak Adane Masresha, Gedefaw Diress Alen, Atitegeb Abera Kidie, Amanuel Addisu Dessie, Tadesse Mamo Dejene
Scientific Reports. 2022; 12(1)
[Pubmed]  [Google Scholar] [DOI]
4 Burden of anemia and its association with HAART in HIV infected children in Ethiopia: a systematic review and meta-analysis
Fasil Wagnew,Setegn Eshetie,Animut Alebel,Cheru Tesema,Getiye Dejenu Kibret,Alemu Gebrie,Getenet Dessie,Amanuel Alemu Abajobir
BMC Infectious Diseases. 2019; 19(1)
[Pubmed]  [Google Scholar] [DOI]
5 Magnitude and causes of first-line antiretroviral therapy regimen changes among HIV patients in Ethiopia: a systematic review and meta-analysis
Zerihun Ataro,Birhanu Motbaynor,Fitsum Weldegebreal,Mekonnen Sisay,Tewodros Tesfa,Habtamu Mitiku,Dadi Marami,Zelalem Teklemariam,Zewdneh Shewamene
BMC Pharmacology and Toxicology. 2019; 20(1)
[Pubmed]  [Google Scholar] [DOI]
6 Reasons for Antiretroviral Treatment Change Among Adult HIVAIDS Patients at Nedjo General Hospital, Western Ethiopia
Ginenus Fekadu,Lencho Bati,Habte Gebeyehu
The Open AIDS Journal. 2019; 13(1): 65
[Pubmed]  [Google Scholar] [DOI]
7 Modification of Initial Highly Active Antiretroviral Therapy (HAART) Regimen in Paediatric HIV Patients
Yee Shan Low,Farida Islahudin,Kamarul Azahar Mohd Razali,Shafnah Adnan
The Open AIDS Journal. 2018; 12(1): 11
[Pubmed]  [Google Scholar] [DOI]
8 Reasons for switching ART: Comparison of data collected in 2012–2013 and 2014–2015 in Florence, Italy
Francesco Maria Fusco,Maria Chiara Burla,Anna Degli Esposti,Piera Pierotti,Loredana Rabatti,Francesca Vichi
International Journal of STD & AIDS. 2018; 29(4): 392
[Pubmed]  [Google Scholar] [DOI]
9 Antiretroviral changes during the first year of therapy
Antonio Carlos Policarpo Carmo Sá Bandeira,Darcielle Bruna Dias Elias,Malena Gadelha Cavalcante,Denise Girão Limaverde Lima,Lara Gurgel Fernandes Távora
Revista da Associação Médica Brasileira. 2017; 63(7): 606
[Pubmed]  [Google Scholar] [DOI]
10 Motives for change of first-line antiretroviral therapy regimens in an unselected cohort of HIV/AIDS patients at a major referral centre in South-west Cameroon
Christian Akem Dimala,Ndemazie Nkafu Bechem,Desmond Aroke,Benjamin Momo Kadia
BMC Research Notes. 2017; 10(1)
[Pubmed]  [Google Scholar] [DOI]
11 Choice of initial antiretroviral drugs and treatment outcomes among HIV-infected patients in sub-Saharan Africa: systematic review and meta-analysis of observational studies
Tadesse Awoke Ayele,Alemayehu Worku,Yigzaw Kebede,Kassahun Alemu,Adetayo Kasim,Ziv Shkedy
Systematic Reviews. 2017; 6(1)
[Pubmed]  [Google Scholar] [DOI]
12 Liver enzyme elevations in a cohort of HIV/AIDS patients on first-line antiretroviral therapy in Namibia: Findings and implications
P.A. Mataranyika,D. Kibuule,F. Kalemeera,H. Kaura,B. Godman,T.W. Rennie
Alexandria Journal of Medicine. 2017;
[Pubmed]  [Google Scholar] [DOI]
13 Multi-state models for the analysis of time-to-treatment modification among HIV patients under highly active antiretroviral therapy in Southwest Ethiopia
Belay Birlie,Roel Braekers,Tadesse Awoke,Adetayo Kasim,Ziv Shkedy
BMC Infectious Diseases. 2017; 17(1)
[Pubmed]  [Google Scholar] [DOI]
14 Clinical analysis of HIV/AIDS patients with drug eruption in Yunnan, China
Yu-Ye Li,Yong-Mei Jin,Li-Ping He,Jin-Song Bai,Jun Liu,Min Yu,Jian-Hua Chen,Jing Wen,Yi-Qun Kuang
Scientific Reports. 2016; 6: 35938
[Pubmed]  [Google Scholar] [DOI]
15 Antiretroviral Treatment Switching and Its Association With Economic Outcomes and Adverse Treatment Effects Among Commercially Insured and Medicaid-Enrolled Patients With HIV in the United States
Jennifer S. Korsnes,Bridgett B. Goodwin,Miranda Murray,Sean D. Candrilli
Annals of Pharmacotherapy. 2016; 50(12): 989
[Pubmed]  [Google Scholar] [DOI]
16 Reasons for Treatment Changes in Patients With Moderate to Severe Psoriasis
Kathryn L. Anderson,Steven R. Feldman
Journal of Cutaneous Medicine and Surgery. 2015; 19(4): 361
[Pubmed]  [Google Scholar] [DOI]
17 Incidence rate of modifying or discontinuing first combined antiretroviral therapy regimen due to toxicity during the first year of treatment stratified by age
Thiago Silva Torres,Sandra Wagner Cardoso,Luciane S. Velasque,Valdilea G. Veloso,Beatriz Grinsztejn
The Brazilian Journal of Infectious Diseases. 2013;
[Pubmed]  [Google Scholar] [DOI]
18 Inhibitors of HIV-1 entry
Micewicz, E.D. and Ruchala, P.
Current Pharmaceutical Design. 2013; 19(10): 1784-1799
[Pubmed]  [Google Scholar]
19 Evaluation of adverse events associated with antiretroviral therapy and the relationship to treatment adherence
Lenzi, L. and Wiens, A. and Pontarolo, R.
International Journal of Clinical Pharmacology and Therapeutics. 2013; 51(2): 141-146
[Pubmed]  [Google Scholar]


Read this article